Your browser doesn't support javascript.
loading
Statin drug use is not associated with prostate cancer risk in men who are regularly screened.
Platz, Elizabeth A; Tangen, Catherine M; Goodman, Phyllis J; Till, Cathee; Parnes, Howard L; Figg, William D; Albanes, Demetrius; Neuhouser, Marian L; Klein, Eric A; Lucia, M Scott; Thompson, Ian M; Kristal, Alan R.
Afiliação
  • Platz EA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland. Electronic address: eplatz@jhu.edu.
  • Tangen CM; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Goodman PJ; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Till C; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Parnes HL; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
  • Figg WD; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
  • Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
  • Neuhouser ML; Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Klein EA; Center for Clinical and Translational Research, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio.
  • Lucia MS; University of Colorado Denver School of Medicine, Aurora, Colorado.
  • Thompson IM; Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio, Texas.
  • Kristal AR; Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
J Urol ; 192(2): 379-84, 2014 Aug.
Article em En | MEDLINE | ID: mdl-24518774
PURPOSE: Prospective cohort studies support the hypothesis that statin drug users have a lower risk of aggressive prostate cancer. Whether statin drug use influences the risk of screen detected disease is less clear, possibly because of complex detection biases. Thus, we investigated this association in a setting in which men had low baseline serum prostate specific antigen concentration and were screened annually. MATERIALS AND METHODS: We performed a cohort study of 9,457 men 55 years old or older at randomization to the placebo arm of PCPT (Prostate Cancer Prevention Trial). The men reported new use of medications quarterly. We estimated the multivariable adjusted HR of prostate cancer (574 cases in 62,192 person-years) for statin drug use and duration of use during the trial using Cox proportional hazards regression. RESULTS: During 7 years of followup statin drug use during the trial was not associated with the risk of total prostate cancer (HR 1.03, 95% CI 0.82-1.30), or lower grade (HR 0.96, 95% CI 0.71-1.29) or higher grade (HR 1.27, 95% CI 0.85-1.90) prostate cancer. Duration of use during followup was also not associated with the risk of total, or lower or higher grade disease (p trend=0.7, 0.5 and 0.2, respectively). CONCLUSIONS: These prospective results do not support the hypothesis that statin drugs protect against prostate cancer in the setting of regular prostate cancer screening.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Inibidores de Hidroximetilglutaril-CoA Redutases Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Humans / Male / Middle aged Idioma: En Revista: J Urol Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Inibidores de Hidroximetilglutaril-CoA Redutases Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Humans / Male / Middle aged Idioma: En Revista: J Urol Ano de publicação: 2014 Tipo de documento: Article